Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals

Clinical and Experimental Immunology
F D ShiH Link

Abstract

Nasal administration of microg doses of acetylcholine receptor (AChR) is effective in preventing the development of B cell-mediated EAMG in the Lewis rat, a model for human MG. In order to investigate whether nasal administration of AChR modulates ongoing EAMG, Lewis rats were treated nasally with AChR 2 weeks after immunization with AChR and Freund's complete adjuvant. Ten-fold higher amounts of AChR given nasally (600 microg/rat) were required to ameliorate the manifestations of EAMG compared with the amounts necessary for prevention of EAMG. In lymph node cells from rats receiving 600 microg/rat of AChR, AChR-induced proliferation and interferon-gamma (IFN-gamma) secretion were reduced compared with control EAMG rats receiving PBS only. The anti-AChR antibodies in rats treated nasally with 600 microg/rat of AChR had lower affinity, reduced proportion of IgG2b and reduced capacity to induce AChR degradation. Numbers of AChR-reactive IFN-gamma and tumour necrosis factor-alpha (TNF-alpha) mRNA-expressing lymph node cells from rats treated nasally with 600 microg/rat of AChR were suppressed, while IL-4, IL-10 and transforming growth factor-beta (TGF-beta) mRNA-expressing cells were not affected. Collectively, these data indicate...Continue Reading

References

Jan 1, 1976·Annals of the New York Academy of Sciences·V A LennonM E Seybold
Jun 1, 1991·The Journal of Clinical Investigation·H LinkT Olsson
Jul 1, 1991·Clinical Immunology and Immunopathology·R E AhlbergA K Lefvert
Jan 1, 1986·Methods in Enzymology·R DijkemaH Schellekens
Feb 10, 1988·Journal of Immunological Methods·R A MacdonaldC L Jones
Jan 1, 1981·Methods in Enzymology·J LindstromS Tzartos
Jun 23, 1994·The New England Journal of Medicine·D B Drachman
Jan 1, 1993·European Journal of Immunology·J D PetersonS D Miller
Jan 1, 1993·Immunology Today·C M Snapper, J J Mond
Jun 1, 1996·European Journal of Immunology·J A Gracie, J A Bradley
Aug 1, 1996·European Journal of Biochemistry·F HuchoJ Machold
Mar 1, 1996·Immunology Today·T R Mosmann, S Sad
Jul 21, 1998·Annals of the New York Academy of Sciences·M A AgiusR H Fairclough
Jul 21, 1998·Annals of the New York Academy of Sciences·G X ZhangH Link

❮ Previous
Next ❯

Citations

Dec 13, 2006·Clinical & Developmental Immunology·Ana M C Faria, Howard L Weiner
Aug 17, 2011·Therapeutics and Clinical Risk Management·Sivakumar Sathasivam
Dec 21, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·X F Bai, H Link
May 4, 2010·Annals of Neurology·Jie LuoJon M Lindstrom
Jul 29, 2015·Biochemical Pharmacology·Jie Luo, Jon Lindstrom
Mar 20, 2010·Autoimmunity·M C SouroujonS Fuchs
Jul 16, 2005·Expert Opinion on Biological Therapy·Sonia Berrih-AkninMiriam C Souroujon
Jan 19, 2000·Clinical Immunology : the Official Journal of the Clinical Immunology Society·P ChristadossC Deng
Dec 11, 2002·Journal of Autoimmunity·Rui-Sheng DuanBao-Guo Xiao
Oct 20, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S H ImS Fuchs
May 9, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H B WangH G Ljunggren
May 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S H ImM C Souroujon
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S H ImS Fuchs
Dec 28, 1999·Microbes and Infection·W Chen, S M Wahl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.